// App-Quantinova.ai

TCT-352 : Proportion of Ischemic Risk After PCI Mediated by High Platelet Reactivity on Clopidogrel: Analysis From the ADAPT-DES Study

Researchers

Presenter

  • Bjorn Redfors

Principal Investigators

  • Ori Ben-Yehuda

  • Sheng-Hsuan Lin

  • Ariel Furer

  • Ajay Kirtane

  • Bernhard Witzenbichler

  • Giora Weisz

  • Thomas Stuckey

  • Akiko Maehara

  • Philippe Genereux

  • Gennaro Giustino

Medical Centers

  • FirstHealth Cardiology Services, Pinehurst, North Carolina, United States

  • The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

  • Cardiovascular Research Foundation and Columbia University Medical Center, New York, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Wellmont CVA Heart Institute, Kingsport, United States

  • Cone Health Heart and Vascular Center, Greensboro, North Carolina, United States

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • CUMC, New York, New York, United States

  • Newyork Presbyterian Hospital, Newyork, New York, United States

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • Cedars Sinai Medical Center, Los Angeles, California, United States

  • Cardiovascular Research Foundation, Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Cardiovascular Research Foundation, New York, United States

  • Sanger Heart and Vascular Institute/Carolinas Medical Center, Charlotte, North Carolina, United States

  • Columbia University Medical Center/Hopital du Sacre-Coeur de Montreal, New York, New York, United States

  • Department of Biostatistics, Columbia Mailman School of Public Health, New York, New York, United States

  • Lehigh Valley Health Network, Allentown, Pennsylvania, United States

  • Helios Amper-Klinikum Dachau, Berlin, Germany

Locations

  • United States

  • Germany

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim